These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35061079)

  • 1. A comparative analysis of MRI findings in endometrial cancer: differentiation between endometrioid adenocarcinoma, serous carcinoma, and clear cell carcinoma.
    Mori T; Kato H; Kawaguchi M; Hatano Y; Ishihara T; Noda Y; Hyodo F; Matsuo M; Furui T; Morishige KI
    Eur Radiol; 2022 Jun; 32(6):4128-4136. PubMed ID: 35061079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging-based radiomics analysis of the differential diagnosis of ovarian clear cell carcinoma and endometrioid carcinoma: a retrospective study.
    Takeyama N; Sasaki Y; Ueda Y; Tashiro Y; Tanaka E; Nagai K; Morioka M; Ogawa T; Tate G; Hashimoto T; Ohgiya Y
    Jpn J Radiol; 2024 Jul; 42(7):731-743. PubMed ID: 38472624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apparent diffusion coefficient (ADC) values of serous, endometrioid, and clear cell carcinoma of the ovary: pathological correlation.
    Ono T; Kishimoto K; Tajima S; Maeda I; Takagi M; Suzuki N; Mimura H
    Acta Radiol; 2020 Jul; 61(7):992-1000. PubMed ID: 31698924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrioid adenocarcinoma of the ovary: MRI findings with emphasis on diffusion-weighted imaging for the differentiation of ovarian tumors.
    Kovač JD; Terzić M; Mirković M; Banko B; Đikić-Rom A; Maksimović R
    Acta Radiol; 2016 Jun; 57(6):758-66. PubMed ID: 26307063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary.
    Morioka S; Kawaguchi R; Yamada Y; Iwai K; Yoshimoto C; Kobayashi H
    J Ovarian Res; 2019 Feb; 12(1):20. PubMed ID: 30803452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical Comparison of Ovarian and Uterine Endometrioid Carcinoma, Endometrioid Carcinoma With Clear Cell Change, and Clear Cell Carcinoma.
    Lim D; Ip PP; Cheung AN; Kiyokawa T; Oliva E
    Am J Surg Pathol; 2015 Aug; 39(8):1061-9. PubMed ID: 25871622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can the apparent diffusion coefficient differentiate the grade of endometrioid adenocarcinoma and the histological subtype of endometrial cancer?
    Yan B; Zhao T; Liang X; Niu C; Ding C
    Acta Radiol; 2018 Mar; 59(3):363-370. PubMed ID: 28696169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis.
    Tanaka YO; Okada S; Satoh T; Matsumoto K; Oki A; Saida T; Yoshikawa H; Minami M
    Cancer Imaging; 2016 Feb; 16():3. PubMed ID: 26873307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-tumor ADC histogram analysis for differentiating endometriosis-related tumors: seromucinous borderline tumor, clear cell carcinoma and endometrioid carcinoma.
    Lu J; Zhao S; Ma F; Li H; Li Y; Qiang J
    Abdom Radiol (NY); 2023 Feb; 48(2):724-732. PubMed ID: 36401131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary ovarian endometrioid adenocarcinoma: magnetic resonance imaging findings including a preliminary observation on diffusion-weighted imaging.
    Li HM; Qiang JW; Xia GL; Zhao SH; Ma FH; Cai SQ; Feng F; Fu AY
    J Comput Assist Tomogr; 2015; 39(3):401-5. PubMed ID: 25978592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of intranuclear inclusions is useful for the cytological diagnosis of ovarian clear cell carcinoma.
    Naka M; Ohishi Y; Kaku T; Watanabe S; Tamiya S; Ookubo F; Kato K; Oda Y; Sugishima S
    Diagn Cytopathol; 2015 Nov; 43(11):879-84. PubMed ID: 26219930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging for distinguishing ovarian clear cell carcinoma from high-grade serous carcinoma.
    Ma FH; Qiang JW; Zhang GF; Li HM; Cai SQ; Rao YM
    J Ovarian Res; 2016 Jul; 9(1):40. PubMed ID: 27377917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas.
    Uehara Y; Oda K; Ikeda Y; Koso T; Tsuji S; Yamamoto S; Asada K; Sone K; Kurikawa R; Makii C; Hagiwara O; Tanikawa M; Maeda D; Hasegawa K; Nakagawa S; Wada-Hiraike O; Kawana K; Fukayama M; Fujiwara K; Yano T; Osuga Y; Fujii T; Aburatani H
    PLoS One; 2015; 10(6):e0128066. PubMed ID: 26043110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of diffusion-weighted MRI in the differential diagnosis of endometrioid and non-endometrioid cancer of the uterus.
    Bakir VL; Bakir B; Sanli S; Yildiz SO; Iyibozkurt AC; Kartal MG; Yavuz E
    Acta Radiol; 2017 Jun; 58(6):758-767. PubMed ID: 27664276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clear cell carcinoma of the ovary: comparison of MR findings of histological subtypes.
    Kato H; Hatano Y; Makino H; Furui T; Morishige KI; Matsuo M
    Abdom Radiol (NY); 2016 Dec; 41(12):2476-2483. PubMed ID: 27167231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative discrimination of tumour stage in clear cell carcinoma of the ovary using computed tomography and magnetic resonance imaging.
    Joo HL; Shin YR; Rha SE; Park CS; Shim DJ; Kim K
    Eur J Radiol; 2018 Dec; 109():19-26. PubMed ID: 30527303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted MRI at 3T in Endometrial Cancer: Correlation of Apparent Diffusion Coefficient with Histopathological Prognostic Parameters.
    Ozturk M; Kalkan C; Danaci M; Kefeli M
    J Coll Physicians Surg Pak; 2021 Dec; 31(12):1399-1405. PubMed ID: 34794277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference in Diffusion-Weighted Magnetic Resonance Imaging and Diffusion Tensor Imaging Parameters Between Endometrioid Endometrial Adenocarcinoma and Uterine Serous Adenocarcinoma: A Retrospective Study.
    Tian S; Liu A; Zhu W; Li Y; Chen L; Chen A; Shen J; Song Q; Wei Q
    Int J Gynecol Cancer; 2017 Oct; 27(8):1708-1713. PubMed ID: 28945213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The apparent diffusion coefficient (ADC) on 3-T MRI differentiates myometrial invasion depth and histological grade in patients with endometrial cancer.
    Reyes-Pérez JA; Villaseñor-Navarro Y; Jiménez de Los Santos ME; Pacheco-Bravo I; Calle-Loja M; Sollozo-Dupont I
    Acta Radiol; 2020 Sep; 61(9):1277-1286. PubMed ID: 31955608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes.
    Alkushi A; Köbel M; Kalloger SE; Gilks CB
    Int J Gynecol Pathol; 2010 Jul; 29(4):343-50. PubMed ID: 20567148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.